omniture

WuXi AppTec Named a Top Ten Chinese Outsourcing Enterprise

Dr. Ge Li, Chairman and CEO, Named a Top Ten Contributor to China's Outsourcing Industry


SHANGHAI, June 16, 2011 /PRNewswire-Asia/ -- WuXi AppTec announced today that it has been selected as one of the Top Ten Outsourcing Enterprises in China for 2011 by China's Ministry of Commerce. The list was announced at China's Fourth Annual International Service Outsourcing Cooperation Conference, held in Nanjing on June 10, 2011. Dr. Ge Li, Chairman and Chief Executive Officer of WuXi AppTec, was named a Top Ten Contributor to China's Outsourcing Industry.

The conference was hosted by China's Ministry of Commerce, China's Council for the Promotion of International Trade, and the Jiangsu Provincial People's Government. Outsourcing companies from 21 countries, including the United States, Japan, Canada, the United Kingdom, France, the Netherlands, and South Korea, attended.  The conference highlighted the importance of Chinese outsourcing enterprises and their growing capabilities for developing business in North America, Europe, and Japan. These enterprises continue to show strong current growth and remarkable potential for future growth within China's dynamic economic environment.

"WuXi AppTec is honored to be selected to this list, and I am personally gratified with my own award," Dr. Li commented. "WuXi AppTec is the leading China-based CRO, offering world-class capabilities and unparalleled capacities for the world's leading pharmaceutical and biotech companies. We provide fully integrated R&D services to improve the success of research and shorten the time of development of new products."

For more information, please contact:

 

 

 

 

    Ronald Aldridge

 

 

    Director of Investor Relations

 

 

    WuXi PharmaTech (Cayman) Inc.

 

 

    Tel:   +1-201-585-2048

 

 

    Email: Ron_Aldridge@wuxiapptec.com

 

 

 

 

    Stephanie Liu (for the media)

 

 

    Tel:   +86-21-5046-4362

 

 

    Email: pr@wuxiapptec.com

 

 

 




Source: WuXi PharmaTech (Cayman) Inc.
Related Stocks:
NYSE:WX
collection